| Management of benzodiazepine misuse and dependence J Brett, B Murnion Australian prescriber 38 (5), 152, 2015 | 263 | 2015 |
| Low-value care in Australian public hospitals: prevalence and trends over time T Badgery-Parker, SA Pearson, K Chalmers, J Brett, IA Scott, S Dunn, ... BMJ quality & safety 28 (3), 205-214, 2019 | 89 | 2019 |
| Psychotropic medication use in Australia, 2007 to 2015: changes in annual incidence, prevalence and treatment exposure J Brett, EA Karanges, B Daniels, NA Buckley, C Schneider, A Nassir, ... Australian & New Zealand Journal of Psychiatry 51 (10), 990-999, 2017 | 76 | 2017 |
| Benzodiazepine use in older adults in the United States, Ontario, and Australia from 2010 to 2016 J Brett, DT Maust, Z Bouck, RV Ignacio, G Mecredy, EA Kerr, S Bhatia, ... Journal of the American Geriatrics Society 66 (6), 1180-1185, 2018 | 54 | 2018 |
| Concerns about quetiapine J Brett Australian prescriber 38 (3), 95, 2015 | 52 | 2015 |
| Clenbuterol toxicity: a NSW poisons information centre experience J Brett, AH Dawson, JA Brown Medical journal of Australia 200 (4), 219-221, 2014 | 52 | 2014 |
| A model averaging/selection approach improves the predictive performance of model‐informed precision dosing: vancomycin as a case study DW Uster, SL Stocker, JE Carland, J Brett, DJE Marriott, RO Day, ... Clinical Pharmacology & Therapeutics 109 (1), 175-183, 2021 | 51 | 2021 |
| Developing indicators for measuring low-value care: mapping Choosing Wisely recommendations to hospital data K Chalmers, T Badgery-Parker, SA Pearson, J Brett, IA Scott, AG Elshaug BMC research notes 11, 1-8, 2018 | 50 | 2018 |
| Trends in opioid utilisation in Australia, 2006‐2015: insights from multiple metrics EA Karanges, NA Buckley, J Brett, B Blanch, M Litchfield, L Degenhardt, ... Pharmacoepidemiology and drug safety 27 (5), 504-512, 2018 | 47 | 2018 |
| Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients CB Cunio, DW Uster, JE Carland, H Buscher, Z Liu, J Brett, M Stefani, ... Clinical Microbiology and Infection 27 (5), 783. e7-783. e14, 2021 | 39 | 2021 |
| Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study J Brett, B Daniels, EA Karanges, NA Buckley, C Schneider, A Nassir, ... British journal of clinical pharmacology 83 (11), 2581-2588, 2017 | 38 | 2017 |
| ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004–2014 R Cairns, B Daniels, DA Wood, J Brett Medical Journal of Australia 204 (4), 154-154, 2016 | 34 | 2016 |
| The relative lethal toxicity of pharmaceutical and illicit substances: A 16‐year study of the Greater Newcastle Hunter Area, Australia J Brett, CE Wylie, J Raubenheimer, GK Isbister, NA Buckley British journal of clinical pharmacology 85 (9), 2098-2107, 2019 | 27 | 2019 |
| Measuring 21 low-value hospital procedures: claims analysis of Australian private health insurance data (2010–2014) K Chalmers, SA Pearson, T Badgery-Parker, J Brett, IA Scott, AG Elshaug BMJ open 9 (3), e024142, 2019 | 26 | 2019 |
| A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: an Australian case study J Brett, AG Elshaug, RS Bhatia, K Chalmers, T Badgery-Parker, ... Implementation Science 12, 1-13, 2017 | 26 | 2017 |
| Pregabalin to treat ciguatera fish poisoning J Brett, B Murnion Clinical toxicology 53 (6), 588-588, 2015 | 25 | 2015 |
| Misuse and associated harms of quetiapine and other atypical antipsychotics ME Montebello, J Brett Non-medical and illicit use of psychoactive drugs, 125-139, 2017 | 24 | 2017 |
| Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study AL Schaffer, D Busingye, K Chidwick, J Brett, S Blogg BJGP open 5 (1), 2021 | 23 | 2021 |
| Correlates of higher‐risk drug‐related behaviours at music festivals in New South Wales, Australia A Healey, KJ Siefried, ME Harrod, E Franklin, A Peacock, MJ Barratt, ... Drug and Alcohol Review 41 (2), 320-329, 2022 | 20 | 2022 |
| Evaluation of a pilot vancomycin precision dosing advisory service on target exposure attainment using an interrupted time series analysis SL Stocker, JE Carland, SE Reuter, AE Stacy, AL Schaffer, M Stefani, ... Clinical Pharmacology & Therapeutics 109 (1), 212-221, 2021 | 20 | 2021 |
